FSCVX
Price
$26.75
Change
-$0.10 (-0.37%)
Updated
Dec 2 closing price
Net Assets
270.61M
VSIAX
Price
$91.20
Change
+$0.97 (+1.08%)
Updated
Dec 3 closing price
Net Assets
58.35B
Interact to see
Advertisement

FSCVX vs VSIAX

Header iconFSCVX vs VSIAX Comparison
Open Charts FSCVX vs VSIAXBanner chart's image
Nuveen Small Cap Value C
Price$26.75
Change-$0.10 (-0.37%)
VolumeN/A
Net Assets270.61M
Vanguard Small Cap Value Index Admiral
Price$91.20
Change+$0.97 (+1.08%)
VolumeN/A
Net Assets58.35B
FSCVX vs VSIAX Comparison Chart in %
View a ticker or compare two or three
VS
FSCVX vs. VSIAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCVX is a Hold and VSIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 58.3B vs. FSCVX (271M). VSIAX pays higher dividends than FSCVX: VSIAX (1.97) vs FSCVX (0.56). FSCVX was incepted earlier than VSIAX: FSCVX (27 years) vs VSIAX (14 years). FSCVX (2.06) is less costly to investors than VSIAX (0.07). FSCVX is a more actively managed with annual turnover of: 23.00 vs. VSIAX (16.00). FSCVX (3000) and VSIAX (3000) have matching initial minimum investment requirements. VSIAX annual gain was more profitable for investors over the last year : -1.65 vs. FSCVX (-5.84). FSCVX (56.61) and VSIAX (56.54) have equivalent 5 years return.
FSCVXVSIAXFSCVX / VSIAX
Total Expense Ratio1.950.072,786%
Annual Report Gross Expense Ratio2.060.072,943%
Fund Existence27 years14 years-
Gain YTD2.3646.75435%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets271M58.3B0%
Annual Yield % from dividends0.561.9729%
Returns for 1 year-5.84-1.65354%
Returns for 3 years19.5526.5174%
Returns for 5 years56.6156.54100%
Returns for 10 years55.46113.2649%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRIBX25.96N/A
N/A
MFS Research International B
AHSAX22.75N/A
N/A
Alger Health Sciences A
NBGTX33.64N/A
N/A
Neuberger Berman Large Cap Growth Tr
HADRX85.15N/A
N/A
Horizon Defined Risk Advisor
VSGEX7.51N/A
N/A
Virtus SGA International Growth C